warkentin pi - Search Results

Year	Number of Results
1978	1
1980	2
1981	1
1982	1
1983	3
1984	3
1985	2
1986	2
1987	3
1988	3
1989	1
1991	3
1992	1
1993	1
1994	11
1995	2
1996	1
1997	3
1998	2
1999	2
2000	1
2001	1
2003	3
2013	1
2014	1
2019	1
2021	1
2023	1
2024	1
2025	1
2026	0

1

Improving Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy: Evolution of ASTCT Practice Guidelines and FACT Inspections.

Carpenter PA, Warkentin PI. Carpenter PA, et al. Among authors: warkentin pi. Transplant Cell Ther. 2025 Nov;31(11):843-848. doi: 10.1016/j.jtct.2025.10.008. Transplant Cell Ther. 2025. PMID: 41176371 No abstract available.

2

Characteristics of HPC(A) product obtained from a donor with SARS-CoV-2 infection and outcome of autologous transplant.

Renavikar PS, Warkentin PI, Williams SM, Gundabolu K, Branson C, Koepsell SA. Renavikar PS, et al. Among authors: warkentin pi. Stem Cell Res Ther. 2024 Aug 13;15(1):251. doi: 10.1186/s13287-024-03872-4. Stem Cell Res Ther. 2024. PMID: 39135194 Free PMC article.

3

Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.

Nikiforow S, Frigault MJ, Frey NV, Gardner RA, Komanduri KV, Perales MA, Kebriaei P, Warkentin PI, Pasquini M, Aho JL, Levine BL, Heslop HE, Hlucky TL, Habucky K, Gharibo M, Jagasia M, Locke FL. Nikiforow S, et al. Among authors: warkentin pi. Transplant Cell Ther. 2023 Apr;29(4):228-239. doi: 10.1016/j.jtct.2023.01.021. Epub 2023 Jan 26. Transplant Cell Ther. 2023. PMID: 36709800 Free PMC article.

4

Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE.

McNiece IK, Wacker KK, Kurtzberg J, Warkentin PI. McNiece IK, et al. Among authors: warkentin pi. Cytotherapy. 2021 Oct;23(10):886-893. doi: 10.1016/j.jcyt.2021.02.004. Epub 2021 Mar 26. Cytotherapy. 2021. PMID: 33775525

5

Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model.

LeMaistre CF, Wacker KK, Akard LP, Al-Homsi AS, Gastineau DA, Godder K, Lill M, Selby GB, Steinberg A, Anderson JM, Leahigh AK, Warkentin PI. LeMaistre CF, et al. Among authors: warkentin pi. Biol Blood Marrow Transplant. 2019 Nov;25(11):2243-2250. doi: 10.1016/j.bbmt.2019.06.035. Epub 2019 Jul 5. Biol Blood Marrow Transplant. 2019. PMID: 31284070 Free article.

6

Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.

Patel SA, Coulter DW, Grovas AC, Gordon BG, Harper JL, Warkentin PI, Wisecarver JL, Sanger WG, Coccia PF. Patel SA, et al. Among authors: warkentin pi. J Pediatr Hematol Oncol. 2014 Aug;36(6):491-4. doi: 10.1097/MPH.0000000000000077. J Pediatr Hematol Oncol. 2014. PMID: 24322499 Free PMC article.

7

Successful unrelated cord blood transplantation for homozygous α-thalassemia.

Gumuscu B, Thompson EI, Grovas AC, Zach TL, Warkentin PI, Coccia PF. Gumuscu B, et al. Among authors: warkentin pi. J Pediatr Hematol Oncol. 2013 Oct;35(7):570-2. doi: 10.1097/MPH.0b013e31827e7f6a. J Pediatr Hematol Oncol. 2013. PMID: 23337553

8

Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.

Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ. Horslen SP, et al. Among authors: warkentin pi. Pediatrics. 2003 Jun;111(6 Pt 1):1262-7. doi: 10.1542/peds.111.6.1262. Pediatrics. 2003. PMID: 12777539

9

Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).

Warkentin PI; Foundation for the Accreditation of Cellular Therapy. Warkentin PI, et al. Cytotherapy. 2003;5(4):299-305. doi: 10.1080/14653240310002298. Cytotherapy. 2003. PMID: 12944235 Review.

10

Hematopoietic stem and progenitor cell transplants: regulation and accreditation.

Warkentin PI. Warkentin PI. Pediatr Transplant. 2003;7 Suppl 3:101-8. doi: 10.1034/j.1399-3046.7.s3.16.x. Pediatr Transplant. 2003. PMID: 12603702 No abstract available.

11

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency.

Rubocki RJ, Parsa JR, Hershfield MS, Sanger WG, Pirruccello SJ, Santisteban I, Gordon BG, Strandjord SE, Warkentin PI, Coccia PF. Rubocki RJ, et al. Among authors: warkentin pi. Blood. 2001 Feb 1;97(3):809-11. doi: 10.1182/blood.v97.3.809. Blood. 2001. PMID: 11157502 Free article.

12

FAHCT accreditation: common deficiencies during on-site inspections.

Warkentin PI, Nick L, Shpall EJ. Warkentin PI, et al. Cytotherapy. 2000;2(3):213-20. doi: 10.1080/146532400539170. Cytotherapy. 2000. PMID: 12042044

13

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.

Pirruccello SJ, Page CJ, Bishop MR, Letheby BA, Warkentin PI, Jackson JD, Kessinger A. Pirruccello SJ, et al. Among authors: warkentin pi. Cytotherapy. 1999;1(4):279-86. doi: 10.1080/0032472031000141263. Cytotherapy. 1999. PMID: 20426553

14

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.

Ageitos AG, Varney ML, Bierman PJ, Vose JM, Warkentin PI, Talmadge JE. Ageitos AG, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1999 Jan;23(1):63-9. doi: 10.1038/sj.bmt.1701524. Bone Marrow Transplant. 1999. PMID: 10037052

15

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.

Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC. Fox IJ, et al. Among authors: warkentin pi. N Engl J Med. 1998 May 14;338(20):1422-6. doi: 10.1056/NEJM199805143382004. N Engl J Med. 1998. PMID: 9580649 Free article. No abstract available.

16

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.

Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, Bierman PJ, Vose JM, Warkentin PI, Gross TG, Nasrati K, Armitage JO, Kessinger A, Bishop MR. Pavletic ZS, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1998 Jan;21(1):33-41. doi: 10.1038/sj.bmt.1701037. Bone Marrow Transplant. 1998. PMID: 9486492 Free PMC article.

17

Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.

Bishop MR, Jackson JD, Tarantolo SR, O'Kane-Murphy B, Iversen PL, Bayever E, Joshi SM, Sharp JG, Pierson JL, Warkentin PI, Armitage JO, Kessinger A. Bishop MR, et al. Among authors: warkentin pi. J Hematother. 1997 Oct;6(5):441-6. doi: 10.1089/scd.1.1997.6.441. J Hematother. 1997. PMID: 9368180 Clinical Trial.

18

Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.

Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Gordon BG, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1997 Jul;20(1):5-10. doi: 10.1038/sj.bmt.1700827. Bone Marrow Transplant. 1997. PMID: 9232249

19

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.

Bishop MR, Tarantolo SR, Jackson JD, Anderson JR, Schmit-Pokorny K, Zacharias D, Pavletic ZS, Pirruccello SJ, Vose JM, Bierman PJ, Warkentin PI, Armitage JO, Kessinger A. Bishop MR, et al. Among authors: warkentin pi. J Clin Oncol. 1997 Apr;15(4):1601-7. doi: 10.1200/JCO.1997.15.4.1601. J Clin Oncol. 1997. PMID: 9193359

20

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.

Bishop MR, Jackson JD, O'Kane-Murphy B, Schmit-Pokorny K, Vose JM, Bierman PJ, Warkentin PI, Armitage JO, Garrison L, Kessinger A. Bishop MR, et al. Among authors: warkentin pi. J Clin Oncol. 1996 Sep;14(9):2521-6. doi: 10.1200/JCO.1996.14.9.2521. J Clin Oncol. 1996. PMID: 8823331 Clinical Trial.

21

Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.

Kessinger A, Bishop MR, Jackson JD, O'Kane-Murphy B, Vose JM, Bierman PJ, Reed EC, Warkentin PI, Armitage JO, Sharp JG. Kessinger A, et al. Among authors: warkentin pi. Exp Hematol. 1995 Jul;23(7):609-12. Exp Hematol. 1995. PMID: 7601251 Clinical Trial.

22

Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.

Kessinger A, Bishop MR, Anderson JR, Armitage JO, Bierman PJ, Reed EC, Tarantolo S, Tempero MA, Vose JM, Warkentin PI. Kessinger A, et al. Among authors: warkentin pi. J Hematother. 1995 Apr;4(2):81-4. doi: 10.1089/scd.1.1995.4.81. J Hematother. 1995. PMID: 7543352 Clinical Trial.

23

Fatal eosinophilic disease following autologous bone marrow transplantation.

Gross TG, Hoge FJ, Jackson JD, Sammut PH, Warkentin PI. Gross TG, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1994 Aug;14(2):333-7. Bone Marrow Transplant. 1994. PMID: 7994253

24

Comparison of sterility profiles from slaughterhouse versus surgically removed pancreata for islet isolation with a new semiclosed method involving the COBE 2991.

Damon-Burke M, Warkentin PI, Jackson JD, Weide LG. Damon-Burke M, et al. Among authors: warkentin pi. Transplant Proc. 1994 Apr;26(2):625-7. Transplant Proc. 1994. PMID: 8171585 No abstract available.

25

Semiclosed system for human and porcine islet isolation using the COBE 2991 cell processor with the triple-bag processing sets.

Weide LG, Damon-Burke M, Warkentin PI. Weide LG, et al. Among authors: warkentin pi. Transplant Proc. 1994 Apr;26(2):608-9. Transplant Proc. 1994. PMID: 8171578 No abstract available.

26

Sterility profile for human pancreatic islet harvests using a new semiclosed method involving the COBE 2991.

Damon-Burke M, Warkentin PI, Jackson JD, Weide LG. Damon-Burke M, et al. Among authors: warkentin pi. Transplant Proc. 1994 Apr;26(2):603-5. Transplant Proc. 1994. PMID: 8171576 No abstract available.

27

High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.

Bishop MR, Anderson JR, Jackson JD, Bierman PJ, Reed EC, Vose JM, Armitage JO, Warkentin PI, Kessinger A. Bishop MR, et al. Among authors: warkentin pi. Blood. 1994 Jan 15;83(2):610-6. Blood. 1994. PMID: 7904489 Free article. Clinical Trial.

28

Hematopoietic progenitor cells frozen in ampules are satisfactory reference vials for bulk freezing.

Jershin B, Jackson JD, Schmidt-Pokorny K, Warkentin PI. Jershin B, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1994;389:657-61. Prog Clin Biol Res. 1994. PMID: 7700933 No abstract available.

29

Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.

Warkentin PI, Jackson JD, Letheby B, Kessinger A. Warkentin PI, et al. Prog Clin Biol Res. 1994;389:643-7. Prog Clin Biol Res. 1994. PMID: 7700931 No abstract available.

30

Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.

Bishop MR, Warkentin PI, Jackson JD, Bayever E, Iversen PL, Whalen VI, Lastovica J, Haines K, Kessinger A. Bishop MR, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1994;389:183-7. Prog Clin Biol Res. 1994. PMID: 7700901 No abstract available.

31

Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.

Jackson JD, Letheby B, O'Kane Murphy B, Costas P, Wang PN, Bishop MR, Kessinger A, Warkentin PI. Jackson JD, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1994;389:471-7. Prog Clin Biol Res. 1994. PMID: 7535456 No abstract available.

32

Characterization of hematopoietic stem cells in human cord blood.

Alter R, O'Kane-Murphy B, Korth D, Costas P, Wang PN, Welniak L, Greally JF, Kuszynski C, Warkentin PI, Jackson JD. Alter R, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1994;389:393-8. Prog Clin Biol Res. 1994. PMID: 7535447 No abstract available.

33

CD34 analysis in erythropoietin mobilized peripheral blood stem cells.

O'Kane-Murphy B, Jackson JD, Kuszynski C, Costas P, Wang PN, Warkentin PI, Kessinger A. O'Kane-Murphy B, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1994;389:371-6. Prog Clin Biol Res. 1994. PMID: 7535444 Clinical Trial. No abstract available.

34

Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.

Gordon BG, Weisenburger DD, Warkentin PI, Anderson J, Sanger WG, Bast M, Gnarra D, Vose JM, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Among authors: warkentin pi. Cancer. 1993 Jan 1;71(1):257-63. doi: 10.1002/1097-0142(19930101)71:1<257::aid-cncr2820710139>3.0.co;2-b. Cancer. 1993. PMID: 8380117

35

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

Gordon BG, Warkentin PI, Weisenburger DD, Vose JM, Sanger WG, Strandjord SE, Anderson JR, Verdirame JD, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Among authors: warkentin pi. Blood. 1992 Dec 1;80(11):2938-42. Blood. 1992. PMID: 1450419 Free article.

36

Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy.

Vaughan WP, Dennison JD, Reed EC, Klassen L, McGuire TR, Sanger WG, Kumar PP, Warkentin PI, Gordon BG, Bierman PJ, et al. Vaughan WP, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1991 Dec;8(6):489-95. Bone Marrow Transplant. 1991. PMID: 1790429

37

Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation.

Gordon BG, Saving KL, McCallister JA, Warkentin PI, McConnell JR, Roberts WM, Coccia PF, Haire WD. Gordon BG, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1991 Oct;8(4):323-5. Bone Marrow Transplant. 1991. PMID: 1756332

38

Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.

Gordon BG, Strandjord SE, Warkentin PI, Kadushin J, Coccia PF. Gordon BG, et al. Among authors: warkentin pi. Am J Pediatr Hematol Oncol. 1991 Spring;13(1):29-33. doi: 10.1097/00043426-199121000-00007. Am J Pediatr Hematol Oncol. 1991. PMID: 2029074

39

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.

Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO. Kessinger A, et al. Among authors: warkentin pi. Bone Marrow Transplant. 1989 Nov;4(6):643-6. Bone Marrow Transplant. 1989. PMID: 2573397

40

Neonatal neutropenia. Clinical manifestations, cause, and outcome.

Baley JE, Stork EK, Warkentin PI, Shurin SB. Baley JE, et al. Among authors: warkentin pi. Am J Dis Child. 1988 Nov;142(11):1161-6. doi: 10.1001/archpedi.1988.02150110039016. Am J Dis Child. 1988. PMID: 3177322

41

Granulocyte transfusions.

Baley JE, Stork EK, Warkentin PI, Shurin SB. Baley JE, et al. Among authors: warkentin pi. Pediatrics. 1988 Jun;81(6):915. Pediatrics. 1988. PMID: 3368292 No abstract available.

42

High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.

Coccia PF, Strandjord SE, Warkentin PI, Cheung NK, Gordon EM, Novak LJ, Shina DC, Herzig RH. Coccia PF, et al. Among authors: warkentin pi. Blood. 1988 Apr;71(4):888-93. Blood. 1988. PMID: 3281725 Free article.

43

Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial.

Baley JE, Stork EK, Warkentin PI, Shurin SB. Baley JE, et al. Among authors: warkentin pi. Pediatrics. 1987 Nov;80(5):712-20. Pediatrics. 1987. PMID: 3670972 Clinical Trial.

44

Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.

Saarinen UM, Strandjord SE, Warkentin PI, Cheung NK, Lazarus HM, Coccia PF. Saarinen UM, et al. Among authors: warkentin pi. Transplantation. 1987 Oct;44(4):540-6. doi: 10.1097/00007890-198710000-00017. Transplantation. 1987. PMID: 3313843

45

Plateletpheresis: an invaluable blood resource.

Warkentin PI. Warkentin PI. Cleve Clin J Med. 1987 Sep-Oct;54(5):381-3. doi: 10.3949/ccjm.54.5.381. Cleve Clin J Med. 1987. PMID: 3665019 Free article. No abstract available.

46

Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.

Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Giebink GS, et al. Among authors: warkentin pi. J Infect Dis. 1986 Oct;154(4):590-6. doi: 10.1093/infdis/154.4.590. J Infect Dis. 1986. PMID: 3528315

47

Bone marrow transplantation in Hunter syndrome: a preliminary report.

Warkentin PI, Dixon MS Jr, Schafer I, Strandjord SE, Coccia PF. Warkentin PI, et al. Birth Defects Orig Artic Ser. 1986;22(1):31-9. Birth Defects Orig Artic Ser. 1986. PMID: 3083885 No abstract available.

48

Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.

Herzig RH, Coccia PF, Lazarus HM, Strandjord SE, Graham-Pole J, Cheung NK, Gordon EM, Gross S, Spitzer TR, Warkentin PI, et al. Herzig RH, et al. Among authors: warkentin pi. Semin Oncol. 1985 Jun;12(2 Suppl 3):184-6. Semin Oncol. 1985. PMID: 3892700 No abstract available.

49

Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch.

Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Warkentin PI, et al. Vox Sang. 1985;48(2):89-104. doi: 10.1111/j.1423-0410.1985.tb00152.x. Vox Sang. 1985. PMID: 2416122

50

Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.

Lazarus HM, Coccia PF, Herzig RH, Graham-Pole J, Gross S, Strandjord S, Gordon E, Cheung NK, Warkentin PI, Spitzer TR, et al. Lazarus HM, et al. Among authors: warkentin pi. Blood. 1984 Jul;64(1):215-20. Blood. 1984. PMID: 6375759 Free article.

51

More on calculations for exchange transfusion.

Warkentin PI. Warkentin PI. Transfusion. 1984 Jan-Feb;24(1):86. doi: 10.1046/j.1537-2995.1984.24184122574.x. Transfusion. 1984. PMID: 6695447 No abstract available.

52

Role of the blood bank in bone marrow transplantation.

McCullough J, Lasky LC, Warkentin PI. McCullough J, et al. Among authors: warkentin pi. Prog Clin Biol Res. 1984;149:379-412. Prog Clin Biol Res. 1984. PMID: 6429666

53

Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.

Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J. Lasky LC, et al. Among authors: warkentin pi. Transfusion. 1983 Jul-Aug;23(4):277-85. doi: 10.1046/j.1537-2995.1983.23483276858.x. Transfusion. 1983. PMID: 6410549

54

Transfusion of patients undergoing bone marrow transplantation.

Warkentin PI. Warkentin PI. Hum Pathol. 1983 Mar;14(3):261-6. doi: 10.1016/s0046-8177(83)80028-8. Hum Pathol. 1983. PMID: 6403451

55

Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation.

Warkentin PI, Yomtovian R, Hurd D, Brunning R, Swanson J, Kersey JH, McCullough J. Warkentin PI, et al. Vox Sang. 1983;45(1):40-7. doi: 10.1111/j.1423-0410.1983.tb04120.x. Vox Sang. 1983. PMID: 6349125

56

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

Filipovich AH, McGlave PB, Ramsay NK, Goldstein G, Warkentin PI, Kesey JH. Filipovich AH, et al. Among authors: warkentin pi. Lancet. 1982 Jun 5;1(8284):1266-9. doi: 10.1016/s0140-6736(82)92840-9. Lancet. 1982. PMID: 6123018

57

Successful engraftment of NA1 positive bone marrow in a patient with a neutrophil antibody, anti-NA1.

Warkentin PI, Clay ME, Kersey JH, Ramsay NK, McCullough J. Warkentin PI, et al. Hum Immunol. 1981 Mar;2(2):173-84. doi: 10.1016/0198-8859(81)90064-1. Hum Immunol. 1981. PMID: 7021491

58

Philadelphia chromosome positive childhood acute lymphoblastic leukemia.

Priest JR, Robison LL, McKenna RW, Lindquist LL, Warkentin PI, LeBien TW, Woods WG, Kersey JH, Coccia PF, Nesbit ME Jr. Priest JR, et al. Among authors: warkentin pi. Blood. 1980 Jul;56(1):15-22. Blood. 1980. PMID: 6930307 Free article.

59

Successful bone-marrow transplantation for infantile malignant osteopetrosis.

Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NK, Warkentin PI, Teitelbaum SL, Kahn AJ, Brown DM. Coccia PF, et al. Among authors: warkentin pi. N Engl J Med. 1980 Mar 27;302(13):701-8. doi: 10.1056/NEJM198003273021301. N Engl J Med. 1980. PMID: 6986555

60

Sclerodermatous graft-versus-host disease limited to an area of measles exanthem.

Fenyk JR Jr, Smith CM, Warkentin PI, Krivit W, Goltz RW, Neely JE, Nesbit ME, Ramsay NK, Coccia PF, Kersey JH. Fenyk JR Jr, et al. Among authors: warkentin pi. Lancet. 1978 Mar 4;1(8062):472-3. doi: 10.1016/s0140-6736(78)90136-8. Lancet. 1978. PMID: 76022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year